Breakthrough vaccine targets pancreatic cancer cells, showing promise in preclinical trials and paving the way for human testing.

Scientists at UC San Francisco have discovered how pancreatic cancer cells thrive in the lungs or liver, environments that are as distinct to cells as the ocean and desert are to animals. The ...

In an interview, Arvind Bussetty, MD, and Arvind Trindade, MD, delved into the rising rates of gastrointestinal cancers among younger patients.

Know the symptoms: Pancreatic cancerThis year, approximately 1,000 Alabama residents will be diagnosed with pancreatic cancer. With a trending increase in cases for patients under the age of 55, ...

Liver shunts occur when blood flow from the abdominal organs like the intestines, pancreas, stomach and spleen bypass the liver and proceed right to the vena cava and general circulation.

Find a pancreatic cancer specialist or cancer treatment center, including high-volume surgeons, near you and learn about getting a second opinion.

Patients with a family history of pancreatic cancer would likely be among the first candidates to receive such treatments. For now, fighting pancreatic cancer remains a race against time.

The five-year survival rate of people diagnosed with pancreatic cancer is currently 13 percent. Two breakthroughs are bringing hope for successfully treating this malignancy.

A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage pancreatic cancer patients.

Scientists have developed a blood test called PAC-MANN that is said to be less invasive, cheaper and more robust than traditional screening methods for pancreatic cancer.

Pancreatic cancer can cause symptoms such as diarrhea and constipation. Learn more about how pancreatic cancer can affect stool, treatment options, and more.

Pancreatic cysts are often found incidentally on imaging tests for other indications. Imaging, symptom assessment, and laboratory tests can help distinguish benign cysts from those associated with ...